UA81743C2 (uk) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
US6902734B2 (en) | 2000-08-07 | 2005-06-07 | Centocor, Inc. | Anti-IL-12 antibodies and compositions thereof |
KR20100120246A (ko) | 2001-11-14 | 2010-11-12 | 센토코 오르토 바이오테크 인코포레이티드 | 항 il-6 항체, 조성물, 방법 및 용도 |
PE20061324A1 (es) | 2005-04-29 | 2007-01-15 | Centocor Inc | Anticuerpos anti-il-6, composiciones, metodos y usos |
TR201902033T4 (tr) | 2005-06-30 | 2019-03-21 | Janssen Biotech Inc | Anti-IL-23 antikorları, bileşimleri, yöntemleri ve kullanımları. |
KR20130108481A (ko) | 2005-08-19 | 2013-10-02 | 아보트 러보러터리즈 | 이원 가변 도메인 면역글로불린 및 이의 용도 |
EP2500356A3 (en) | 2005-08-19 | 2012-10-24 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
HUE034269T2 (en) | 2005-12-29 | 2018-02-28 | Janssen Biotech Inc | Human anti-IL-23 antibodies, preparations, methods and applications |
NZ599144A (en) | 2006-09-08 | 2013-10-25 | Abbott Lab | Interleukin -13 binding proteins |
US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
AU2009241589B2 (en) | 2008-04-29 | 2013-10-10 | Abbvie Inc. | Dual variable domain immunoglobulins and uses thereof |
EP2500361B1 (en) | 2008-05-09 | 2016-03-30 | AbbVie Deutschland GmbH & Co KG | Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof |
EP2297209A4 (en) | 2008-06-03 | 2012-08-01 | Abbott Lab | IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF |
NZ589436A (en) | 2008-06-03 | 2012-12-21 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
EP2810654A1 (en) | 2008-07-08 | 2014-12-10 | AbbVie Inc. | Prostaglandin E2 binding proteins and uses thereof |
US8030026B2 (en) | 2009-02-24 | 2011-10-04 | Abbott Laboratories | Antibodies to troponin I and methods of use thereof |
EP3029070A1 (en) | 2009-08-29 | 2016-06-08 | AbbVie Inc. | Therapeutic dll4 binding proteins |
CN102656190A (zh) | 2009-12-08 | 2012-09-05 | 雅培股份有限两合公司 | 用于在视网膜神经纤维层变性治疗中使用的针对rgm a蛋白质的单克隆抗体 |
BR112012020102A2 (pt) | 2010-02-10 | 2016-11-29 | Immunogen Inc | anticorpos cd20 e usos dos mesmos. |
TWI781327B (zh) | 2010-02-24 | 2022-10-21 | 美商免疫遺傳股份有限公司 | 葉酸受體1抗體類和免疫共軛物類及彼等之用途 |
CN102906113B (zh) | 2010-03-02 | 2015-08-12 | Abbvie公司 | 治疗性dll4结合蛋白 |
LT2552961T (lt) | 2010-03-30 | 2018-02-12 | Janssen Biotech, Inc. | Humanizuoti il-25 antikūnai |
JP2013523182A (ja) | 2010-04-15 | 2013-06-17 | アボット・ラボラトリーズ | アミロイドベータ結合タンパク質 |
WO2012006500A2 (en) | 2010-07-08 | 2012-01-12 | Abbott Laboratories | Monoclonal antibodies against hepatitis c virus core protein |
UY33492A (es) | 2010-07-09 | 2012-01-31 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
WO2012018790A2 (en) | 2010-08-03 | 2012-02-09 | Abbott Laboratories | Dual variable domain immunoglobulins and uses thereof |
WO2012024187A1 (en) | 2010-08-14 | 2012-02-23 | Abbott Laboratories | Amyloid-beta binding proteins |
CA2808577C (en) | 2010-08-19 | 2018-09-25 | Abbott Laboratories | Anti-ngf antibodies and their use |
WO2012088094A2 (en) | 2010-12-21 | 2012-06-28 | Abbott Laboratories | Il-1 binding proteins |
BR112013015944A2 (pt) | 2010-12-21 | 2018-06-19 | Abbvie Inc | imunoglobulinas de domínio duplo variável il-1 alpha e beta biespecífico e seus usos. |
AU2011352205B2 (en) | 2010-12-31 | 2016-06-16 | Bioatla, Llc | Express humanization of antibodies |
CA2841970A1 (en) | 2011-07-13 | 2013-01-17 | Abbvie Inc. | Methods and compositions for treating asthma using anti-il-13 antibodies |
CN104203978A (zh) | 2011-10-24 | 2014-12-10 | 艾伯维股份有限公司 | 针对硬化蛋白的免疫结合剂 |
KR102080535B1 (ko) | 2011-11-23 | 2020-02-24 | 메디뮨 엘엘씨 | Her3에 특이적인 결합 분자 및 이의 용도 |
EA201400993A1 (ru) | 2012-03-08 | 2015-05-29 | Галозим, Инк. | Антитела против рецептора эпидермального фактора роста, активные в определенных условиях, и способы их применения |
HRP20200482T1 (hr) | 2012-08-31 | 2020-06-26 | Immunogen, Inc. | Dijagnostičke analize i setovi za detekciju folat receptora 1 |
US9550986B2 (en) | 2012-12-21 | 2017-01-24 | Abbvie Inc. | High-throughput antibody humanization |
CA2906417C (en) | 2013-03-14 | 2022-06-21 | Robert Ziemann | Hcv core lipid binding domain monoclonal antibodies |
RU2725825C2 (ru) | 2013-08-30 | 2020-07-06 | Иммьюноджен Инк. | Антитела и методы анализа для обнаружения рецептора фолиевой кислоты 1 |
HK1226081A1 (zh) | 2013-09-12 | 2017-09-22 | Halozyme, Inc. | 修飾的抗表皮生長因子受體抗體及其使用方法 |
ES2814150T3 (es) | 2014-04-08 | 2021-03-26 | Boston Pharmaceuticals Inc | Moléculas de unión específicas para IL-21 y usos de las mismas |
US20160129108A1 (en) | 2014-11-11 | 2016-05-12 | Medimmune Limited | Therapeutic combinations comprising anti-cd73 antibodies and uses thereof |
CN107530423B (zh) | 2015-01-14 | 2022-04-05 | 布里格姆及妇女医院股份有限公司 | 用抗lap单克隆抗体治疗癌症 |
HK1248718A1 (zh) | 2015-05-29 | 2018-10-19 | Abbvie Inc. | 抗cd40抗體及其用途 |
RS61452B9 (sr) | 2015-06-29 | 2021-12-31 | Immunogen Inc | Anti-cd123 antitela i njihovi konjugati i derivati |
EP3719039B1 (en) | 2015-11-10 | 2023-07-26 | MedImmune, LLC | Binding molecules specific for asct2 and uses thereof |
RS66251B1 (sr) | 2016-03-10 | 2024-12-31 | Acceleron Pharma Inc | Proteini koji se vezuju za aktivin tip 2 receptor i njihova primena |
WO2017161206A1 (en) | 2016-03-16 | 2017-09-21 | Halozyme, Inc. | Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use |
KR20180128471A (ko) | 2016-03-29 | 2018-12-03 | 얀센 바이오테크 인코포레이티드 | 항-il12 및/또는 항-il23 항체의 증가된 투여 간격을 사용한 건선의 치료 |
AU2017252574B2 (en) | 2016-04-22 | 2024-08-22 | Acceleron Pharma Inc. | ALK7 binding proteins and uses thereof |
AU2017258097B2 (en) | 2016-04-27 | 2019-10-24 | Abbvie Inc. | Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies |
RS62040B1 (sr) | 2016-06-02 | 2021-07-30 | Abbvie Inc | Agonist receptora glukokortikoida i njegovi imunokonjugati |
PL3458479T4 (pl) | 2016-06-08 | 2021-07-26 | Abbvie Inc. | Przeciwciała anty-b7-h3 i koniugaty przeciwciało-lek |
BR112018075653A2 (pt) | 2016-06-08 | 2019-08-27 | Abbvie Inc | anticorpos anti-b7-h3 e conjugados anticorpo fármaco |
EP3469000A1 (en) | 2016-06-08 | 2019-04-17 | AbbVie Inc. | Anti-b7-h3 antibodies and antibody drug conjugates |
GB201610198D0 (en) | 2016-06-10 | 2016-07-27 | Ucb Biopharma Sprl | Anti-ige antibodies |
TW201825515A (zh) | 2017-01-04 | 2018-07-16 | 美商伊繆諾金公司 | Met抗體以及其免疫結合物及用途 |
WO2018186831A1 (en)* | 2017-04-04 | 2018-10-11 | Hewlett-Packard Development Company, L.P. | Electronic device control based on rotation angle of display units |
US10571973B2 (en) | 2017-04-28 | 2020-02-25 | Apple Inc. | Magnetic sensors for electronic devices |
IL314764A (en) | 2017-09-05 | 2024-10-01 | Immunogen Inc | Methods for detection of folate receptor 1 in a patient sample |
WO2019075090A1 (en) | 2017-10-10 | 2019-04-18 | Tilos Therapeutics, Inc. | ANTI-LAP ANTIBODIES AND USES THEREOF |
CA3102441C (en) | 2018-06-08 | 2023-06-13 | Crystal Bioscience Inc. | Transgenic animal for producing diversified antibodies that have the same light chain i |
WO2020014306A1 (en) | 2018-07-10 | 2020-01-16 | Immunogen, Inc. | Met antibodies and immunoconjugates and uses thereof |
JP2022504839A (ja) | 2018-10-10 | 2022-01-13 | ティロス・セラピューティクス・インコーポレイテッド | 抗lap抗体変異体及びその使用 |
US20220332800A1 (en) | 2018-11-20 | 2022-10-20 | Takeda Vaccines, Inc. | Novel anti-zika virus antibodies and uses thereof |
CN111290569B (zh)* | 2018-12-07 | 2023-09-29 | 纬创资通(昆山)有限公司 | 电源控制方法与使用此方法的电子装置 |
EP3897117A1 (en) | 2018-12-21 | 2021-10-27 | Compass Therapeutics LLC | Transgenic mouse expressing common human light chain |
US20220153827A1 (en) | 2019-01-15 | 2022-05-19 | Janssen Biotech, Inc. | Anti-TNF Antibody Compositions and Methods for the Treatment of Juvenile Idiopathic Arthritis |
IL284794B1 (en) | 2019-01-23 | 2025-06-01 | Janssen Biotech Inc | Anti-TNF antibody preparations for use in methods of treating psoriatic arthritis |
JP7635137B2 (ja) | 2019-03-14 | 2025-02-25 | ヤンセン バイオテツク,インコーポレーテツド | 抗tnf抗体組成物を産生するための方法 |
CA3133388A1 (en) | 2019-03-14 | 2020-09-17 | Janssen Biotech, Inc. | Methods for producing anti-tnf antibody compositions |
CA3133381A1 (en) | 2019-03-14 | 2020-09-17 | Janssen Biotech, Inc. | Manufacturing methods for producing anti-tnf antibody compositions |
MX2021014882A (es) | 2019-06-03 | 2022-03-25 | Janssen Biotech Inc | Anticuerpos anti-tnf, composiciones y métodos para el tratamiento de la espondilitis anquilosante activa. |
US20220323580A1 (en) | 2019-06-03 | 2022-10-13 | Janssen Biotech, Inc. | Anti-tnf antibody compositions, and methods for the treatment of psoriatic arthritis |
WO2021028752A1 (en) | 2019-08-15 | 2021-02-18 | Janssen Biotech, Inc. | Anti-tfn antibodies for treating type i diabetes |
US11422590B2 (en)* | 2019-10-01 | 2022-08-23 | Dell Products, L.P. | IHS (information handling system) operations in response to lid state transitions |
EP4100435A1 (en) | 2020-02-05 | 2022-12-14 | Larimar Therapeutics, Inc. | Tat peptide binding proteins and uses thereof |
US11392190B2 (en)* | 2020-02-27 | 2022-07-19 | Dell Products L.P. | System and method for utilizing a tablet kickstand to power up an information handling system |
EP4132971A1 (en) | 2020-04-09 | 2023-02-15 | Merck Sharp & Dohme LLC | Affinity matured anti-lap antibodies and uses thereof |
US11795225B2 (en) | 2020-09-11 | 2023-10-24 | Medimmune Limited | Therapeutic binding molecules |
CN116615455A (zh) | 2020-09-12 | 2023-08-18 | 免疫医疗有限公司 | 用于抗b7h4抗体-药物缀合物疗法的评分方法 |
AR124681A1 (es) | 2021-01-20 | 2023-04-26 | Abbvie Inc | Conjugados anticuerpo-fármaco anti-egfr |
BR112023018353A2 (pt) | 2021-03-12 | 2024-02-06 | Janssen Biotech Inc | Método seguro e eficaz para tratamento da artrite psoriática com anticorpo específico anti-il23 |
US20220289834A1 (en) | 2021-03-12 | 2022-09-15 | Janssen Biotech, Inc. | Method of Treating Psoriatic Arthritis Patients with Inadequate Response to TNF Therapy with Anti-IL23 Specific Antibody |
WO2022197782A1 (en) | 2021-03-17 | 2022-09-22 | Receptos Llc | Methods of treating atopic dermatitis with anti il-13 antibodies |
US20240174758A1 (en) | 2021-03-18 | 2024-05-30 | Medimmune Limited | Therapeutic binding molecules |
EP4337689A1 (en) | 2021-05-12 | 2024-03-20 | Applied Biomedical Science Institute | Binding polypeptides against sars cov-2 and uses thereof |
EP4367138A1 (en) | 2021-07-09 | 2024-05-15 | Janssen Biotech, Inc. | Manufacturing methods for producing anti-il12/il23 antibody compositions |
CN117957251A (zh) | 2021-07-09 | 2024-04-30 | 詹森生物科技公司 | 用于制备抗tnf抗体组合物的制造方法 |
WO2023281462A1 (en) | 2021-07-09 | 2023-01-12 | Janssen Biotech, Inc. | Manufacturing methods for producing anti-tnf antibody compositions |
CA3236779A1 (en) | 2021-10-29 | 2023-05-04 | Janssen Biotech, Inc. | Methods of treating crohn's disease with anti-il23 specific antibody |
US20230151087A1 (en) | 2021-11-15 | 2023-05-18 | Janssen Biotech, Inc. | Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody |
AU2022396102A1 (en) | 2021-11-23 | 2024-07-11 | Janssen Biotech, Inc. | Method of treating ulcerative colitis with anti-il23 specific antibody |
TW202348252A (zh) | 2022-02-16 | 2023-12-16 | 英商梅迪繆思有限公司 | 用治療性結合分子治療癌症的組合療法 |
US20230312703A1 (en) | 2022-03-30 | 2023-10-05 | Janssen Biotech, Inc. | Method of Treating Psoriasis with IL-23 Specific Antibody |
WO2023223265A1 (en) | 2022-05-18 | 2023-11-23 | Janssen Biotech, Inc. | Method for evaluating and treating psoriatic arthritis with il23 antibody |
CN117631756A (zh)* | 2022-08-09 | 2024-03-01 | 北京小米移动软件有限公司 | 设备控制方法、装置、设备、介质及程序产品 |
US20240199734A1 (en) | 2022-11-22 | 2024-06-20 | Janssen Biotech, Inc. | Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody |
US12265434B2 (en)* | 2023-02-27 | 2025-04-01 | Dell Products L.P. | Disregarding spurious power-on and power-off triggers |
WO2025027472A2 (en) | 2023-07-31 | 2025-02-06 | Astrazeneca Ab | Cd123 antibody-drug conjugates and methods of using the same |